Current Ratio in % of MERRIMACK PHARMACEUTICALS INC from Q3 2012 to Q1 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Merrimack Pharmaceuticals Inc quarterly Current Ratio history and change rate from Q3 2012 to Q1 2024.
  • Merrimack Pharmaceuticals Inc Current Ratio for the quarter ending 31 Mar 2024 was 1.26K %, a 63.6% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

MERRIMACK PHARMACEUTICALS INC Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q1 2024 1.26K -2.2K -63.6% 31 Mar 2024
Q4 2023 4.29K +1.25K +41% 31 Dec 2023
Q3 2023 4K +1.17K +41.4% 30 Sep 2023
Q2 2023 3.8K +1.19K +45.9% 30 Jun 2023
Q1 2023 3.46K +1.13K +48.3% 31 Mar 2023
Q4 2022 3.04K +752 +32.9% 31 Dec 2022
Q3 2022 2.83K +637 +29.1% 30 Sep 2022
Q2 2022 2.6K +1.09K +72.1% 30 Jun 2022
Q1 2022 2.33K +1.15K +97.8% 31 Mar 2022
Q4 2021 2.29K +1.42K +165% 31 Dec 2021
Q3 2021 2.19K +1.47K +203% 30 Sep 2021
Q2 2021 1.51K +900 +147% 30 Jun 2021
Q1 2021 1.18K +521 +79.2% 31 Mar 2021
Q4 2020 865 +258 +42.5% 31 Dec 2020
Q3 2020 722 +158 +28% 30 Sep 2020
Q2 2020 612 +109 +21.7% 30 Jun 2020
Q1 2020 658 +224 +51.7% 31 Mar 2020
Q4 2019 607 +189 +45.3% 31 Dec 2019
Q3 2019 564 +149 +35.8% 30 Sep 2019
Q2 2019 503 +114 +29.2% 30 Jun 2019
Q1 2019 434 +103 +31% 31 Mar 2019
Q4 2018 418 +237 +131% 31 Dec 2018
Q3 2018 416 +291 +232% 30 Sep 2018
Q2 2018 389 +291 +298% 30 Jun 2018
Q1 2018 331 +248 +298% 31 Mar 2018
Q4 2017 181 +64.1 +54.8% 31 Dec 2017
Q3 2017 125 -25 -16.7% 30 Sep 2017
Q2 2017 97.9 -44.7 -31.4% 30 Jun 2017
Q1 2017 83.2 -42.2 -33.7% 31 Mar 2017
Q4 2016 117 +8.45 +7.78% 31 Dec 2016
Q3 2016 150 +60 +66.6% 30 Sep 2016
Q2 2016 143 +37.2 +35.3% 30 Jun 2016
Q1 2016 125 +8.91 +7.65% 31 Mar 2016
Q4 2015 109 -32.7 -23.1% 31 Dec 2015
Q3 2015 90.1 -84.8 -48.5% 30 Sep 2015
Q2 2015 105 -123 -54% 30 Jun 2015
Q1 2015 117 -137 -54.1% 31 Mar 2015
Q4 2014 141 -108 -43.3% 31 Dec 2014
Q3 2014 175 -78.9 -31.1% 30 Sep 2014
Q2 2014 229 -17.2 -7% 30 Jun 2014
Q1 2014 254 -70.6 -21.8% 31 Mar 2014
Q4 2013 249 -88.1 -26.1% 31 Dec 2013
Q3 2013 254 -63.6 -20% 30 Sep 2013
Q2 2013 246 30 Jun 2013
Q1 2013 324 31 Mar 2013
Q4 2012 337 31 Dec 2012
Q3 2012 317 30 Sep 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.